KQ

Kelly Qiao

Investor at B Capital

Hong Kong

Overview

Kelly Qiao is a Healthcare Investor at B Capital in Hong Kong, specializing in life sciences, biotechnology, and clinical development. With a Ph.D. from Tsinghua University and experience investing in companies like MacroLux Medical Technology Co., Grit Biotechnology, and HiFiBiO Therapeutics, Kelly has a strong background in venture capital and a keen focus on healthcare innovation.

Work Experience

BC

B Capital

Senior Principal
2021 - Current

B Capital Group is a venture capital firm that backs global entrepreneurs in the field of information technology.

b.capital

MM

MacroLux Medical Technology Co., Ltd.

Investor and Observer
2024

SI

Spectrumedics International

Investor and Board
2024

GB

Grit Biotechnology

Investor and Observer
2023

AS

AlphaLife Sciences

Investor and Observer
2022

P

ProfoundBio

Investor and Observer
2022

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Raised $247,000,000.00 from Lilly Asia Ventures, Ally Bridge Group, T. Rowe Price, Janus Henderson Investors, LYFE Capital, Logos Capital, Piper Heartland Healthcare Capital, LifeSci Venture Partners, Medicxi and Surveyor Capital.

profoundbio.com

BY